Submission for OMB Review; 30-Day Comment Request; Iwin: Navigating Your Path to Well-Being, 32764-32765 [2016-12164]

Download as PDF 32764 Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices 6701 Rockledge Drive, Room 7208, Bethesda, MD 20892, 301–435–0303, hurstj@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS). Dated: May 18, 2016. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–12133 Filed 5–23–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: May 19, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meetings [FR Doc. 2016–12175 Filed 5–23–16; 8:45 am] BILLING CODE 4140–01–P sradovich on DSK3TPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; ‘‘Review of Support of Competitive Research (SCORE) applications’’. Date: June 24, 2016. Time: 1:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, Room 3An.12N, 45 Center Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Shinako Takada, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3An.22, Bethesda, MD 20892–6200, 301–402–9448, shinako.takada@nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Regional Consortia for High Resolution Cryoelectron Microscopy. Date: June 29, 2016. Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, Room 3An.12N, 45 Center VerDate Sep<11>2014 17:24 May 23, 2016 Jkt 238001 Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Margaret J. Weidman, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18B, Bethesda, MD 20892, 301–594–3663. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/ contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20). Date: June 15–16, 2016. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892–9750, 240–276–6343, schweinfestcw@mail.nih.gov. PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Name of Committee: National Cancer Institute Special Emphasis Panel; Therapeutic Agents. Date: June 15, 2016. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W238, Bethesda, MD 20892–9750, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Program Project (P01) SEP V. Date: June 22, 2016. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W126, Bethesda, MD 20892–9750, 240–276– 6348, lymanc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: May 19, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–12171 Filed 5–23–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Iwin: Navigating Your Path to Well-Being Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institute on Drug Abuse (NIDA), the National Institutes of Health, has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on March 1, 2016, page 10640 and allowed SUMMARY: E:\FR\FM\24MYN1.SGM 24MYN1 32765 Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institute on Drug Abuse (NIDA), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more appropriate intervention content at the right time. It integrates Transtheoretical Model of Behavior Change based tailoring, SMS messaging, stage of change matched activities, and engaging game-like features in a cutting edge multiple behavior change program. The first year of this project will focus on the completion of development and beta testing of the app. In year 2, the efficacy of the Iwin program will be determined by tests of statistical significance indicating that participants in the Treatment condition had lower scores on an index of substance use and other behavioral risks than the control group at 6 and 9 month follow-up. The overall design is a 2 group (treatment and control group) by 3 Occasions with repeated measures across occasions. Once shown to be effective, the Iwin program will assist organizations that serve military personnel to meet the directives of both the DoD and CJCS indicating that prevention programs be evidence based, evaluated by the specified populations and address full Total Force Fitness paradigm rather than a single behavior. OMB approval is requested for 1 year. There are no capital, operating, and/or maintenance costs. The total estimated annualized burden hours are 1,760. information on the proposed project, contact*: Dr. Belinda Sims, Health Scientist, DESPR, PRB, National Institute on Drug Abuse, 6001 Executive Boulevard Room 5153, MSC 9589 Bethesda, Maryland 20892–9589,-tollfree number (301) 402–1533 or Email your request, including your address to: bsims@nida.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: Iwin: Navigating your Path to Well-Being, 0925–NEW, National Institute on Drug Abuse (NIDA,) National Institutes of Health (NIH). Need and Use of Information Collection: The overarching objective of this proposal is to conduct a randomized trial to evaluate the effectiveness of the Individual Well-Being Navigator (Iwin) mobile application, a substance abuse prevention and well-being enhancement program designed specifically for military personnel. Iwin provides an innovative, tailored mobile application using best practices in behavior change science and innovative technology to assist military personnel in preventing substance abuse and enhancing wellbeing by providing them with the most ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average time per response (in hours) Form name Type of respondent Number of respondents Screening (Attachment 3) ................. Baseline (Attachment 4) ................... Follow-up Outcome Assessments (6 and 9 month) (Attachment 5). Consent Form (Attachment 1) .......... Military Personnel ............................. ........................................................... ........................................................... 1,624 ........................ 812 1 1 2 10/60 45/60 30/60 271 600 812 ........................................................... ........................ 1 5/60 68 Total ........................................... ........................................................... 2,436 4872 ........................ 1,760 Dated: May 28, 2016. Genevieve R. deAlmeida Project Clearance Liaison, NIDA, NIH. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. [FR Doc. 2016–12164 Filed 5–23–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES sradovich on DSK3TPTVN1PROD with NOTICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. VerDate Sep<11>2014 17:24 May 23, 2016 Jkt 238001 Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; NIEHS R13 Conference Grants Applications. Date: June 7, 2016. Time: 12:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Total annual burden hour Place: NIEHS, Keystone Building, K–2164/ 2166, 530 Davis Drive, Morriville, NC 27713 (Telephone Conference Call). Contact Person: Janice B. Allen, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Science, P.O. Box 12233, MD EC–30/ Room 3170 B, Research Triangle Park, NC 27709, 919/541–7556. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Breast Cancer and the Environment Communication Research Initiative. Date: June 10, 2016. Time: 11:30 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: NIEHS/National Institutes of Health, Keystone, 530 Davis Drive, Research Triangle Park, NC 27709. E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Pages 32764-32765]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12164]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Submission for OMB Review; 30-Day Comment Request; Iwin:
Navigating Your Path to Well-Being

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institute on Drug Abuse (NIDA), the
National Institutes of Health, has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below. This proposed information
collection was previously published in the Federal Register on March 1,
2016, page 10640 and allowed

[[Page 32765]]

60-days for public comment. No public comments were received. The
purpose of this notice is to allow an additional 30 days for public
comment. The National Institute on Drug Abuse (NIDA), National
Institutes of Health, may not conduct or sponsor, and the respondent is
not required to respond to, an information collection that has been
extended, revised, or implemented on or after October 1, 1995, unless
it displays a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact*: Dr. Belinda
Sims, Health Scientist, DESPR, PRB, National Institute on Drug Abuse,
6001 Executive Boulevard Room 5153, MSC 9589 Bethesda, Maryland 20892-
9589,-toll-free number (301) 402-1533 or Email your request, including
your address to: bsims@nida.nih.gov. Formal requests for additional
plans and instruments must be requested in writing.
Proposed Collection: Iwin: Navigating your Path to Well-Being,
0925-NEW, National Institute on Drug Abuse (NIDA,) National Institutes
of Health (NIH).

Need and Use of Information Collection:

The overarching objective of this proposal is to conduct a
randomized trial to evaluate the effectiveness of the Individual Well-
Being Navigator (Iwin) mobile application, a substance abuse prevention
and well-being enhancement program designed specifically for military
personnel. Iwin provides an innovative, tailored mobile application
using best practices in behavior change science and innovative
technology to assist military personnel in preventing substance abuse
and enhancing well-being by providing them with the most appropriate
intervention content at the right time. It integrates Transtheoretical
Model of Behavior Change based tailoring, SMS messaging, stage of
change matched activities, and engaging game-like features in a cutting
edge multiple behavior change program. The first year of this project
will focus on the completion of development and beta testing of the
app. In year 2, the efficacy of the Iwin program will be determined by
tests of statistical significance indicating that participants in the
Treatment condition had lower scores on an index of substance use and
other behavioral risks than the control group at 6 and 9 month follow-
up. The overall design is a 2 group (treatment and control group) by 3
Occasions with repeated measures across occasions. Once shown to be
effective, the Iwin program will assist organizations that serve
military personnel to meet the directives of both the DoD and CJCS
indicating that prevention programs be evidence based, evaluated by the
specified populations and address full Total Force Fitness paradigm
rather than a single behavior.
OMB approval is requested for 1 year. There are no capital,
operating, and/or maintenance costs. The total estimated annualized
burden hours are 1,760.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Type of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Screening (Attachment 3)...... Military 1,624 1 10/60 271
Personnel.
Baseline (Attachment 4)....... ................ .............. 1 45/60 600
Follow-up Outcome Assessments ................ 812 2 30/60 812
(6 and 9 month) (Attachment
5).
Consent Form (Attachment 1)... ................ .............. 1 5/60 68
---------------------------------------------------------------
Total..................... ................ 2,436 4872 .............. 1,760
----------------------------------------------------------------------------------------------------------------

Dated: May 28, 2016.
Genevieve R. deAlmeida
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2016-12164 Filed 5-23-16; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.